Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal, while Simpson Thacher advised KKR. Charlesbank Capital Partners and its portfolio company Ensono signed a definitive agreement...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Repertoire Immune Medicines on the deal. Repertoire Immune Medicines announced the completion of its $189 million Series B financing. Joining Flagship Pioneering, Repertoire’s...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Dotmatics, while Willkie Farr & Gallagher LLP advised Insightful Science on the deal. Insightful Science, a leading software provider serving the global...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) and its affiliate QED Therapeutics, Inc. announced a global collaboration and licensing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal. Charlesbank Capital Partners, a middle-market private investment firm, announced that an affiliated fund has made a significant...
You must be a Standard 1 Year member to access this content.
